发明名称 |
GENE EXPRESSION MARKERS (FAP) FOR COLORECTAL CANCER PROGNOSIS |
摘要 |
Disclosed is a method of predicting clinical outcome for a human subject following surgical resection of colorectal cancer, the method comprising: a.) Determining a normalised level of RNA transcript of FAP, or an expression product thereof, in a biological sample comprising cancer cells obtained from said human subject; and b.) Predicting the likelihood of a positive clinical outcome for said human subject by comparing said normalised level to gene expression data obtained from colorectal cancer reference samples derived from patients with colorectal cancer, wherein increased normalised level of an RNA transcript of FAP, or an expression product thereof, is negatively correlated with an increased likelihood of a positive clinical outcome.
|
申请公布号 |
NZ593224(A) |
申请公布日期 |
2012.10.26 |
申请号 |
NZ20070593224 |
申请日期 |
2007.01.11 |
申请人 |
GENOMIC HEALTH, INC.;NSABP FOUNDATION, INC. |
发明人 |
COWENS, WAYNE;BAKER, JOFFRE B;CLARK, KIM;HACKETT, JAMES;WATSON, DREW;PAIK, SOONMYUNG |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|